Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver X Receptor Exerts Anti-Inflammatory Effects in Colonic Epithelial Cells via ABCA1 and Its Expression Is Decreased in Human and Experimental Inflammatory Bowel Disease.
Miranda-Bautista J, Rodríguez-Feo JA, Puerto M, López-Cauce B, Lara JM, González-Novo R, Martín-Hernández D, Ferreiro-Iglesias R, Bañares R, Menchén L. Miranda-Bautista J, et al. Among authors: menchen l. Inflamm Bowel Dis. 2021 Oct 18;27(10):1661-1673. doi: 10.1093/ibd/izab034. Inflamm Bowel Dis. 2021. PMID: 33609028
Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy.
Miranda-Bautista J, de Gracia-Fernández C, López-Ibáñez M, Barrientos M, Gallo-Moltó A, González-Arias M, González-Gil C, Díaz-Redondo A, Marín-Jiménez I, Menchén L. Miranda-Bautista J, et al. Among authors: menchen l. Dig Dis Sci. 2015 Jul;60(7):2130-5. doi: 10.1007/s10620-015-3577-0. Epub 2015 Feb 14. Dig Dis Sci. 2015. PMID: 25680875
Incidence, management, and course of cancer in patients with inflammatory bowel disease.
Algaba A, Guerra I, Marín-Jiménez I, Quintanilla E, López-Serrano P, García-Sánchez MC, Casis B, Taxonera C, Moral I, Chaparro M, Martín-Rodríguez D, Martín-Arranz MD, Manceñido N, Menchén L, López-Sanromán A, Castaño Á, Bermejo F. Algaba A, et al. Among authors: menchen l. J Crohns Colitis. 2015 Apr;9(4):326-33. doi: 10.1093/ecco-jcc/jjv032. Epub 2015 Feb 16. J Crohns Colitis. 2015. PMID: 25687203
A new role for reticulon-4B/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease.
Rodríguez-Feo JA, Puerto M, Fernández-Mena C, Verdejo C, Lara JM, Díaz-Sánchez M, Álvarez E, Vaquero J, Marín-Jiménez I, Bañares R, Menchén L. Rodríguez-Feo JA, et al. Among authors: menchen l. Am J Physiol Gastrointest Liver Physiol. 2015 Jun 15;308(12):G981-93. doi: 10.1152/ajpgi.00309.2014. Epub 2015 Apr 23. Am J Physiol Gastrointest Liver Physiol. 2015. PMID: 25907690 Free article.
Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis.
Taxonera C, Rodríguez C, Bertoletti F, Menchén L, Arribas J, Sierra M, Arias L, Martínez-Montiel P, Juan A, Iglesias E, Algaba A, Manceñido N, Rivero M, Barreiro-de Acosta M, López-Serrano P, Argüelles-Arias F, Gutierrez A, Busquets D, Gisbert JP, Olivares D, Calvo M, Alba C; Collaborators. Taxonera C, et al. Among authors: menchen l. Inflamm Bowel Dis. 2017 Aug;23(8):1394-1402. doi: 10.1097/MIB.0000000000001144. Inflamm Bowel Dis. 2017. PMID: 28671873 Free article.
84 results